Inato Company

Inato automates data structuring and analysis, cross-checks data sources, and provides insights on this data. It features a tool for collecting and analyzing data used in clinical trials, Inato’s AI-powered platform enables pharmaceutical companies to drastically reduce drug development costs. By accelerating clinical trials, Inato helps new therapies arrive to patients faster, and at lower prices
Technology: Artificial Intelligence, Clinical Trials, Health Care, Machine Learning, Pharmaceutical
Industry: Clinical Development
Headquarters: Paris, Ile-de-France, France
Founded Date: 2016-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 9
Total Funding: 15531856
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-02-04
Last Funding Type: Series A

Visit Website
contact@inato.com
https://twitter.com/inatohealth
Register and Claim Ownership